{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:37:12Z","timestamp":1789036632288,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T00:00:00Z","timestamp":1259020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/nrendo.2009.225","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T09:28:56Z","timestamp":1259054936000},"page":"34-41","source":"Crossref","is-referenced-by-count":118,"title":["Effects of amiodarone therapy on thyroid function"],"prefix":"10.1038","volume":"6","author":[{"given":"Janna","family":"Cohen-Lehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,24]]},"reference":[{"key":"BFnrendo2009225_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster, V. et al. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 114, 700\u2013752 (2006).","journal-title":"Circulation"},{"key":"BFnrendo2009225_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2265.2008.03350.x","volume":"70","author":"TS Han","year":"2009","unstructured":"Han, T. S., Williams, G. R. & Vanderpump, M. P. J. Benzofuran derivatives and the thyroid. Clin. Endocrinol. (Oxf.) 70, 2\u201313 (2009).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009225_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","volume":"118","author":"S Basaria","year":"2005","unstructured":"Basaria, S. & Cooper, D. S. Amiodarone and the thyroid. Am. J. Med. 118, 706\u2013714 (2005).","journal-title":"Am. J. Med."},{"key":"BFnrendo2009225_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1540-8167.1992.tb00972.x","volume":"3","author":"S Nattel","year":"1992","unstructured":"Nattel, S., Talajic, M., Fermini, B. & Roy, D. Amiodarone: pharmacology, clinical actions and relationships between them. J. Cardiovasc. Electrophysiol. 3, 266\u2013280 (1992).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrendo2009225_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/FJC.0b013e31818914b6","volume":"52","author":"BN Singh","year":"2008","unstructured":"Singh, B. N. Amiodarone as paradigm for developing new drugs for atrial fibrillation. J. Cardiovasc. Pharmacol. 52, 300\u2013305 (2008).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnrendo2009225_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/105072501300176471","volume":"11","author":"F Bogazzi","year":"2001","unstructured":"Bogazzi, F., Bartalena, L., Gaasperi, M., Braverman, L. E. & Martino, E. The various effects of amiodarone on thyroid function. Thyroid 11, 511\u2013519 (2001).","journal-title":"Thyroid"},{"key":"BFnrendo2009225_CR7","first-page":"240","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino, E., Bartalena, L., Bogazzi, F. & Braverman, L. E. The effects of amiodarone on the thyroid. Endocr. Rev. 22, 240\u2013254 (2001).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2009225_CR8","first-page":"779","volume-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","author":"JM Miller","year":"2007","unstructured":"Miller, J. M. & Zipes, D. P. in Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 8th edn Ch. 33 (eds Libby, P., Zipes, D. P., Mann, D. P. & Bonow, R. O.) 779\u2013830 (Elsevier Science, Philadelphia, 2007)."},{"key":"BFnrendo2009225_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJMct065916","volume":"356","author":"P Zimetbaum","year":"2007","unstructured":"Zimetbaum, P. Amiodarone for atrial fibrillation. N. Engl. J. Med. 356, 935\u2013941 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2009225_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","volume":"298","author":"P Vassallo","year":"2007","unstructured":"Vassallo, P. & Trohman, R. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298, 1312\u20131322 (2007).","journal-title":"JAMA"},{"key":"BFnrendo2009225_CR11","first-page":"1797","volume-title":"Stein's Textbook of Internal Medicine","author":"GS Levey","year":"1994","unstructured":"Levey, G. S. & Klein, I. in Stein's Textbook of Internal Medicine 2nd edn Ch. 297 (ed. Stein, J. H.) 1797\u20131817 (Little, Brown and Company, Boston, 1994)."},{"key":"BFnrendo2009225_CR12","first-page":"52","volume-title":"The Thyroid: A Fundamental and Clinical Text","author":"P Kopp","year":"2005","unstructured":"Kopp, P. in The Thyroid: A Fundamental and Clinical Text, 9th edn Ch. 4B (eds Braverman, L. E. & Utiger, R. D.) 52\u201376 (Lippincott Williams & Wilkins, Philadelphia, 2005)."},{"key":"BFnrendo2009225_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1172\/JCI104807","volume":"42","author":"LE Braverman","year":"1963","unstructured":"Braverman, L. E. & Ingbar, S. H. Changes in thyroidal function during adaptation to large doses of iodide. J. Clin. Invest. 42, 1216\u20131231 (1963).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2009225_CR14","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1210\/endo.140.8.6893","volume":"140","author":"PH Eng","year":"1999","unstructured":"Eng, P. H. et al. Escape from the acute Wolff\u2013Chaikoff effect is associated with a decrease in thyroid sodium\/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140, 3404\u20133410 (1999).","journal-title":"Endocrinology"},{"key":"BFnrendo2009225_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","volume":"86","author":"GH Daniels","year":"2001","unstructured":"Daniels, G. H. Amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab. 86, 3\u20138 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009225_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1089\/thy.2005.15.835","volume":"15","author":"RJ Koenig","year":"2005","unstructured":"Koenig, R. J. Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid 15, 835\u2013840 (2005).","journal-title":"Thyroid"},{"key":"BFnrendo2009225_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/hrt.79.2.121","volume":"79","author":"CM Newman","year":"1998","unstructured":"Newman, C. M., Price, A., Davies, D. W., Gray, T. A. & Weetman, A. P. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 79, 121\u2013127 (1998).","journal-title":"Heart"},{"key":"BFnrendo2009225_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/eje.0.1450059","volume":"145","author":"F Bogazzi","year":"2001","unstructured":"Bogazzi, F. et al. Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level. Eur. J. Endocrinol. 145, 59\u201364 (2001).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2009225_CR19","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/endo.134.5.8156930","volume":"134","author":"L Chiovato","year":"1994","unstructured":"Chiovato, L. et al. Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 134, 2277\u20132282 (1994).","journal-title":"Endocrinology"},{"key":"BFnrendo2009225_CR20","unstructured":"Advisory Committee Meeting of the Cardiovascular and Renal Drug Division of the US Food and Drug Administration. Multaq (Dronedarone) Briefing Document http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/CardiovascularandRenalDrugsAdvisoryCommittee\/UCM134981.pdf (2009)."},{"key":"BFnrendo2009225_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","volume":"91","author":"MD Trip","year":"1991","unstructured":"Trip, M. D., Wiersinga, W. & Plomp, T. A. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am. J. Med. 91, 507\u2013511 (1991).","journal-title":"Am. J. Med."},{"key":"BFnrendo2009225_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","volume":"101","author":"E Martino","year":"1984","unstructured":"Martino, E. et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med. 101, 28\u201334 (1984).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2009225_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","volume":"26","author":"E Martino","year":"1987","unstructured":"Martino, E. et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin. Endocrinol. (Oxf.) 26, 227\u2013237 (1987).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009225_CR24","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1210\/en.2005-1246","volume":"147","author":"S Tedelind","year":"2006","unstructured":"Tedelind, S. et al. Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5\u2032-monophosphate- and iodine-independent mechanism. Endocrinology 147, 2936\u20132943 (2006).","journal-title":"Endocrinology"},{"key":"BFnrendo2009225_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00000441-200603000-00008","volume":"331","author":"JB Schenck","year":"2006","unstructured":"Schenck, J. B., Rizvi, A. A. & Lin, T. Severe primary hypothyroidism manifesting with torsades de pointes. Am. J. Med. Sci. 331, 154\u2013156 (2006).","journal-title":"Am. J. Med. Sci."},{"key":"BFnrendo2009225_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5414\/CNP72079","volume":"72","author":"R Luciani","year":"2009","unstructured":"Luciani, R., Falcone, C., Principe, F., Punzo, G. & Men\u00e8, P. Acute renal failure due to amiodarone-induced hypothyroidism. Clin. Nephrol. 72, 79\u201380 (2009).","journal-title":"Clin. Nephrol."},{"key":"BFnrendo2009225_CR27","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein, I. & Danzi, S. Thyroid disease and the heart. Circulation 116, 1725\u20131735 (2007).","journal-title":"Circulation"},{"key":"BFnrendo2009225_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"MI Surks","year":"2004","unstructured":"Surks, M. I. et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291, 228\u2013238 (2004).","journal-title":"JAMA"},{"key":"BFnrendo2009225_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein, I. & Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501\u2013509 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2009225_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0002-9149(86)80024-8","volume":"58","author":"R Polikar","year":"1986","unstructured":"Polikar, R. et al. Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes. Am. J. Cardiol. 58, 987\u2013991 (1986).","journal-title":"Am. J. Cardiol."},{"key":"BFnrendo2009225_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/thy.1998.8.83","volume":"8","author":"JB Stanbury","year":"1998","unstructured":"Stanbury, J. B. et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8, 83\u2013100 (1998).","journal-title":"Thyroid"},{"key":"BFnrendo2009225_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7326\/0003-4819-126-1-199701010-00009","volume":"126","author":"KJ Harjai","year":"1997","unstructured":"Harjai, K. J. & Licata, A. A. Effects of amiodarone on thyroid function. Ann. Intern. Med. 126, 163\u2013173 (1997).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2009225_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/qjmed\/hcg158","volume":"96","author":"J Sidhu","year":"2003","unstructured":"Sidhu, J. & Jenkins, D. Men are at increased risk of amiodarone-associated thyrotoxicosis in the UK. QJM 96, 949\u2013950 (2003).","journal-title":"QJM"},{"key":"BFnrendo2009225_CR34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","volume":"67","author":"F Bogazzi","year":"2007","unstructured":"Bogazzi, F. et al. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin. Endocrinol. (Oxf.) 67, 533\u2013537 (2007).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009225_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.md.0000123095.65294.34","volume":"83","author":"D Kurnik","year":"2004","unstructured":"Kurnik, D. et al. Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland. Medicine (Baltimore) 83, 107\u2013113 (2004).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrendo2009225_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archinte.1984.00350150071023","volume":"144","author":"JA Amico","year":"1984","unstructured":"Amico, J. A., Richardson, V., Alpert, B. & Klein, I. Clinical and chemical assessment of thyroid function during therapy with amiodarone. Arch. Intern. Med. 144, 487\u2013490 (1984).","journal-title":"Arch. Intern. Med."},{"key":"BFnrendo2009225_CR37","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/jcem.79.5.7962338","volume":"79","author":"L Bartalena","year":"1994","unstructured":"Bartalena, L. et al. Interleukin-6: a marker of thyroid destructive processes? J. Clin. Endocrinol. Metab. 79, 1424\u20131427 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009225_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","volume":"56","author":"SE Eaton","year":"2002","unstructured":"Eaton, S. E., Euinton, H. A., Newman, C. M., Weetman, A. P. & Bennet, W. M. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin. Endocrinol. (Oxf.) 56, 33\u201338 (2002).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009225_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1530\/EJE-08-0553","volume":"159","author":"ML Tanda","year":"2008","unstructured":"Tanda, M. L., Bogazzi, F., Martino, E. & Bartalena, L. Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? Eur. J. Endocrinol. 159, 359\u2013361 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2009225_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/thy.1997.7.541","volume":"7","author":"F Bogazzi","year":"1997","unstructured":"Bogazzi, F. et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7, 541\u2013545 (1997).","journal-title":"Thyroid"},{"key":"BFnrendo2009225_CR41","first-page":"1402","volume":"26","author":"E Martino","year":"1985","unstructured":"Martino, E. et al. Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis. J. Nucl. Med. 26, 1402\u20131407 (1985).","journal-title":"J. Nucl. Med."},{"key":"BFnrendo2009225_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1210\/jc.2008-1907","volume":"94","author":"KH Yiu","year":"2009","unstructured":"Yiu, K. H. et al. Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J. Clin. Endocrinol. Metab. 94, 109\u2013114 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009225_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.0300-0664.2001.01458.x","volume":"56","author":"L Bartalena","year":"2002","unstructured":"Bartalena, L., Bogazzi, F. & Martino, E. Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clin. Endocrinol. (Oxf.) 56, 23\u201324 (2002).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009225_CR44","first-page":"2930","volume":"81","author":"L Bartalena","year":"1996","unstructured":"Bartalena, L. et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J. Clin. Endocrinol. Metab. 81, 2930\u20132933 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009225_CR45","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/circ.105.11.1275","volume":"105","author":"F Osman","year":"2002","unstructured":"Osman, F., Franklyn, J. A., Sheppard, M. C. & Gammage, M. D. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 105, 1275\u20131277 (2002).","journal-title":"Circulation"},{"key":"BFnrendo2009225_CR46","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jc.2002-021874","volume":"88","author":"F Bogazzi","year":"2003","unstructured":"Bogazzi, F. et al. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J. Clin. Endocrinol. Metab. 88, 1999\u20132002 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009225_CR47","unstructured":"Bogazzi, F. et al. Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J. Clin. Endocrinol. Metab. 10.1210\/jc.2009\u20130940."},{"key":"BFnrendo2009225_CR48","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.1990.03440110092034","volume":"263","author":"AP Farwell","year":"1990","unstructured":"Farwell, A. P., Abend, S. L., Huang, S. K., Patwardhan, N. A. & Braverman, L. E. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263, 1526\u20131528 (1990).","journal-title":"JAMA"},{"key":"BFnrendo2009225_CR49","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00268-005-0673-x","volume":"30","author":"J Gough","year":"2006","unstructured":"Gough, J. & Gough, I. R. Total thyroidectomy for amiodarone-induced thyrotoxicosis in patients with severe cardiac disease. World J. Surg. 30, 1957\u20131961 (2006).","journal-title":"World J. Surg."},{"key":"BFnrendo2009225_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0031-6997(24)01350-4","volume":"50","author":"J Wolff","year":"1998","unstructured":"Wolff, J. Perchlorate and the thyroid gland. Pharm. Rev. 50, 89\u2013105 (1998).","journal-title":"Pharm. Rev."},{"key":"BFnrendo2009225_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF03348098","volume":"9","author":"E Martino","year":"1986","unstructured":"Martino, E., Aghini-Lombardi, F., Mariotti, S., Lenziardi, M. & Baschieri, L. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J. Endocrinol. Invest. 9, 201\u2013207 (1986).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2009225_CR52","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","volume":"61","author":"L Bartalena","year":"2004","unstructured":"Bartalena, L. et al. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin. Endocrinol. (Oxf.) 61, 494\u2013502 (2004).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009225_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2165\/00002018-200629030-00006","volume":"29","author":"L Uzan","year":"2006","unstructured":"Uzan, L. et al. Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis. Drug Saf. 29, 231\u2013236 (2006).","journal-title":"Drug Saf."},{"key":"BFnrendo2009225_CR54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMoa0803778","volume":"360","author":"SH Hohnloser","year":"2009","unstructured":"Hohnloser, S. H. et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N. Engl. J. Med. 360, 668\u2013678 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2009225_CR55","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa054686","volume":"357","author":"BN Singh","year":"2007","unstructured":"Singh, B. N. et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N. Engl. J. Med. 357, 987\u2013999 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2009225_CR56","doi-asserted-by":"publisher","first-page":"527.e1","DOI":"10.1016\/j.ahj.2008.06.010","volume":"156","author":"JM Davy","year":"2008","unstructured":"Davy, J. M. et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am. Heart J. 156, 527.e1\u2013527.e9 (2008).","journal-title":"Am. Heart J."},{"key":"BFnrendo2009225_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1527-3466.2005.tb00167.x","volume":"23","author":"S Kathofer","year":"2005","unstructured":"Kathofer, S., Thomas, D. & Karle, C. A. The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovasc. Drug Rev. 23, 217\u2013230 (2005).","journal-title":"Cardiovasc. Drug Rev."},{"key":"BFnrendo2009225_CR58","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0195-668X(03)00321-X","volume":"24","author":"P Touboul","year":"2003","unstructured":"Touboul, P. et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur. Heart J. 24, 1481\u20131487 (2003).","journal-title":"Eur. Heart J."},{"key":"BFnrendo2009225_CR59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0300-8932(09)71027-9","volume":"62","author":"SH Hohnloser","year":"2009","unstructured":"Hohnloser, S. H. New pharmacological options for patients with atrial fibrillation: the ATHENA trial. Rev. Esp. Cardiol. 62, 479\u2013481 (2009).","journal-title":"Rev. Esp. Cardiol."},{"key":"BFnrendo2009225_CR60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2125.2007.02998.x","volume":"64","author":"Y Tschuppert","year":"2007","unstructured":"Tschuppert, Y. et al. Effect of dronedarone on renal function in healthy subjects. Br. J. Clin. Pharmacol. 64, 785\u2013791 (2007).","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T11:31:15Z","timestamp":1739446275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2009.225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,24]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFnrendo2009225"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2009.225","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,24]]}}}